Literature DB >> 9888562

Vasopressin : a potent autocrine/paracrine regulator of mammal adrenal functions.

G Guillon1, E Grazzini, M Andrez, C Breton, M Trueba, C Serradeil-LeGal, G Boccara, S Derick, L Chouinard, N Gallo-Payet.   

Abstract

The control of adrenal functions by locally secreted neuropeptides or neurotransmitters is of great physiological importance. Vasopressin (VP) is one of these autocrine/paracrine regulators. We demonstrated by RT-PCR and perifusion experiments that rat and human adrenal medulla expressed and released vasopressin under basal conditions and under stimulation by acetylcholine. Intra-adrenal concentrations of VP may be sufficient to activate adrenal VP receptors. In the cortex, only the V1a receptor subtype has been detected. It triggered both steroid secretion and cortical growth. In the medulla, both V1a and V1b receptor subtypes were expressed. V1b receptors were mainly present on chromaffin cells and stimulated catecholamine secretion. The role of the V1a receptor remains unclear. Pathophysiological studies also revealed that human pheochromocytoma did not overexpress vasopressin receptors but might oversecrete vasopressin causing high plasma VP concentrations and elevated blood pressure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9888562     DOI: 10.3109/07435809809032672

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  7 in total

1.  Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors.

Authors:  Maithé Corbani; Miguel Trueba; Stoytcho Stoev; Brigitte Murat; Julie Mion; Véra Boulay; Gilles Guillon; Maurice Manning
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

2.  Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats.

Authors:  Christopher Taveau; Catherine Chollet; Ludovic Waeckel; Dorinne Desposito; Daniel G Bichet; Marie-Françoise Arthus; Christophe Magnan; Erwann Philippe; Valerie Paradis; Fabienne Foufelle; Isabelle Hainault; Sofia Enhorning; Gilberto Velho; Ronan Roussel; Lise Bankir; Olle Melander; Nadine Bouby
Journal:  Diabetologia       Date:  2015-01-27       Impact factor: 10.122

Review 3.  Aging and Adrenal Aldosterone Production.

Authors:  Kazutaka Nanba; Anand Vaidya; William E Rainey
Journal:  Hypertension       Date:  2017-12-11       Impact factor: 10.190

4.  Molecular determinants of the adrenal gland functioning related to stress-sensitive hypertension in ISIAH rats.

Authors:  Larisa A Fedoseeva; Leonid O Klimov; Nikita I Ershov; Yury V Alexandrovich; Vadim M Efimov; Arcady L Markel; Olga E Redina
Journal:  BMC Genomics       Date:  2016-12-28       Impact factor: 3.969

Review 5.  Cell-to-cell communication in bilateral macronodular adrenal hyperplasia causing hypercortisolism.

Authors:  Hervé Lefebvre; Céline Duparc; Gaëtan Prévost; Jérôme Bertherat; Estelle Louiset
Journal:  Front Endocrinol (Lausanne)       Date:  2015-04-20       Impact factor: 5.555

Review 6.  A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin.

Authors:  Gaurang P Mavani; Maria V DeVita; Michael F Michelis
Journal:  Front Med (Lausanne)       Date:  2015-03-24

7.  Effect of developmental NMDAR antagonism with CGP 39551 on aspartame-induced hypothalamic and adrenal gene expression.

Authors:  Kate S Collison; Angela Inglis; Sherin Shibin; Soad Saleh; Bernard Andres; Rosario Ubungen; Jennifer Thiam; Princess Mata; Futwan A Al-Mohanna
Journal:  PLoS One       Date:  2018-03-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.